Giving healthcare companies and their stories the exposure they deserve.

THIS WEEK'S FEATURE

Features

Apr 17, 2018

Moberg Pharma parlaying topical niche brands to fuel innovation engine

Apr 17, 2018

Sweden’s Moberg Pharma (OMX:MOB) is focused on maximizing the potential of its market leading position in over-the-counter sales of topical dermatology products to drive development of new therapies for the treatment of nail fungus and mouth pain, especially in cancer patients.

Apr 17, 2018

Past Features

Featured

Apr 10, 2018

Tear Film Innovations readies launch of iLux device for dry eye disease

Apr 10, 2018

Closely-held Tear Film Innovations plans to formally launch at two upcoming medical conferences its iLux medical device to treat Meibomian gland dysfunction, the leading cause of dry eye disease.

Apr 10, 2018

Apr 3, 2018

Myomo scaling up distribution of MyoPro robotic arm brace

Apr 3, 2018

Myomo (NYSE American:MYO) is moving from a controlled introduction over the past few years to a scale up sales and distribution of its MyoPro product line of lightweight, non-invasive, powered arm braces to restore function in paralyzed or weakened arms.

Apr 3, 2018

Mar 27, 2018

Australia tax incentives spurring R&D

Mar 27, 2018

Australia is riding a wave of R&D, thanks to generous government tax incentives, as well as the quality of contract research and speed of performing clinical trials.

Mar 27, 2018

Mar 20, 2018

Vital Therapies pivotal ELAD trial to read out at end of third quarter

Mar 20, 2018

Vital Therapies (NASDAQ:VTL) expects to report top line data from its ELAD pivotal study, known as VTL-308, in patients with severe alcoholic hepatitis (sAH), an acute form of liver failure, by the end of the third quarter of 2018.

Mar 20, 2018